The Chemours Company (CC)
NYSE: CC · Real-Time Price · USD
14.44
+0.02 (0.14%)
At close: Sep 17, 2026, 4:00 PM EDT
14.42
-0.02 (-0.14%)
After-hours: Sep 17, 2026, 5:27 PM EDT
The Chemours Company Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, The Chemours Company stock has a consensus rating of "Buy" and an average price target of $19. The average 1-year stock price forecast is 31.58% higher than the current stock price, while the lowest is $15 (+3.88%) and the highest is $24 (+66.20%).
Price Target: $19 (+31.58%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for The Chemours Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 11, 2026 |
| UBS | UBS | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 25, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $19 → $17 | Hold | Maintains | $19 → $17 | +17.73% | Aug 24, 2026 |
| Alembic Global | Alembic Global | Buy Maintains $30 → $22 | Buy | Maintains | $30 → $22 | +52.35% | Aug 19, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains $15 | Hold | Maintains | $15 | +3.88% | Aug 17, 2026 |
Financial Forecast
Revenue This Year
5.92B
from 5.81B
Increased by 1.96%
Revenue Next Year
6.21B
from 5.92B
Increased by 4.88%
EPS This Year
1.01
from 0.95
Increased by 6.21%
EPS Next Year
1.93
from 1.01
Increased by 91.09%
EPS and Forward PE are based on non-GAAP adjusted numbers.